Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 20.03% | -14.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.03% | -14.64% | |||
| Cost of Revenue | 20.27% | -2.18% | |||
| Gross Profit | 19.49% | -34.04% | |||
| SG&A Expenses | 12.92% | -26.42% | |||
| Depreciation & Amortization | 28.16% | 0.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.35% | -12.32% | |||
| Operating Income | -4.93% | 6.68% | |||
| Income Before Tax | -14.29% | 11.26% | |||
| Income Tax Expenses | 104.12% | 87.48% | |||
| Earnings from Continuing Operations | -17.59% | -6.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -57.81% | 93.10% | |||
| Net Income | -18.95% | -6.01% | |||
| EBIT | -4.93% | 6.68% | |||
| EBITDA | 0.37% | 7.73% | |||
| EPS Basic | -31.17% | -6.35% | |||
| Normalized Basic EPS | -30.99% | 15.74% | |||
| EPS Diluted | -31.17% | -6.10% | |||
| Normalized Diluted EPS | -30.99% | 15.74% | |||
| Average Basic Shares Outstanding | -9.31% | -0.32% | |||
| Average Diluted Shares Outstanding | -9.31% | -0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||